Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-11-11 Sale |
2022-11-15 4:53 pm |
Allovir Inc. | ALVR | VAN BEEK JEROEN B Chief Commercial Officer |
36,592 | $8.1959 | $299,904 | 349,800 (Direct) |
View |
2022-11-10 Sale |
2022-11-14 5:06 pm |
Allovir Inc. | ALVR | Hagen Brett R Chief Accounting Officer |
24,000 | $8.1326 | $195,183 | 75,899 (Direct) |
View |
2022-11-08 Sale |
2022-11-10 5:29 pm |
Allovir Inc. | ALVR | VAN BEEK JEROEN B Chief Commercial Officer |
13,408 | $8.0022 | $107,293 | 386,392 (Direct) |
View |
2022-10-20 Sale(A) |
2022-10-26 4:15 pm |
Allovir Inc. | ALVR | Miller Edward General Counsel |
553 | $9.3607 | $5,176 | 249,377 (Direct) |
View |
2022-10-20 Sale(A) |
2022-10-26 4:15 pm |
Allovir Inc. | ALVR | Atillasoy Ercem See Remarks |
2,095 | $8.7219 | $18,272 | 131,372 (Direct) |
View |
2022-10-20 Sale(A) |
2022-10-26 4:15 pm |
Allovir Inc. | ALVR | Hagen Brett R Chief Accounting Officer |
345 | $9.3607 | $3,229 | 113,233 (Direct) |
View |
2022-10-20 Sale(A) |
2022-10-26 4:15 pm |
Allovir Inc. | ALVR | VAN BEEK JEROEN B Chief Commercial Officer |
1,070 | $9.3607 | $10,016 | 399,800 (Direct) |
View |
2022-10-20 Sale(A) |
2022-10-26 4:15 pm |
Allovir Inc. | ALVR | Sinha Vikas See Remarks 10% Owner |
1,449 | $9.3607 | $13,564 | 1,036,775 (Direct) |
View |
2022-10-19 Sale |
2022-10-24 6:28 pm |
Allovir Inc. | ALVR | Sinha Vikas See Remarks 10% Owner |
1,449 | $9.3607 | $13,564 | 17,711,541 (Indirect Direct) |
View |
2022-10-19 Sale |
2022-10-24 6:26 pm |
Allovir Inc. | ALVR | VAN BEEK JEROEN B Chief Commercial Officer |
1,070 | $9.3607 | $10,016 | 399,800 (Direct) |
View |
2022-10-19 Sale |
2022-10-24 6:25 pm |
Allovir Inc. | ALVR | Hagen Brett R Chief Accounting Officer |
13,679 | $8.4288 | $115,298 | 99,899 (Direct) |
View |
2022-10-19 Sale |
2022-10-24 6:24 pm |
Allovir Inc. | ALVR | Miller Edward General Counsel |
553 | $9.3607 | $5,176 | 442,188 (Indirect Direct) |
View |
2022-10-19 Sale |
2022-10-24 6:23 pm |
Allovir Inc. | ALVR | Atillasoy Ercem See Remarks |
2,095 | $8.7219 | $18,272 | 131,372 (Direct) |
View |
2022-10-19 Sale |
2022-10-21 9:30 pm |
Allovir Inc. | ALVR | Hallal David Director 10% Owner |
600,000 | $8.45 | $5,070,000 | 19,607,546 (Indirect Direct) |
View |
2022-09-29 Sale |
2022-09-30 4:05 pm |
Allovir Inc. | ALVR | Hallal David Director 10% Owner |
400,000 | $7.3523 | $2,940,920 | 20,207,546 (Indirect Direct) |
View |
2022-09-02 Sale |
2022-09-06 4:17 pm |
Allovir Inc. | ALVR | VAN BEEK JEROEN B Chief Commercial Officer |
493 | $7.8888 | $3,889 | 400,870 (Direct) |
View |
2022-08-18 Sale |
2022-08-19 4:05 pm |
Allovir Inc. | ALVR | Brainard Diana Chief Executive Officer |
4,564 | $7.7626 | $35,429 | 637,548 (Direct) |
View |
2022-08-16 Sale |
2022-08-17 5:58 pm |
Allovir Inc. | ALVR | VAN BEEK JEROEN B Chief Commercial Officer |
15,590 | $8.3049 | $129,473 | 401,363 (Direct) |
View |
2022-07-21 Sale |
2022-07-22 4:22 pm |
Allovir Inc. | ALVR | Atillasoy Ercem See Remarks |
1,533 | $5.3784 | $8,245 | 133,467 (Direct) |
View |
2022-07-21 Sale |
2022-07-21 7:13 pm |
Allovir Inc. | ALVR | Hallal David Director 10% Owner |
4,227 | $5.3295 | $22,528 | 17,353,750 (Indirect Direct) |
View |
2022-07-20 Sale |
2022-07-21 7:12 pm |
Allovir Inc. | ALVR | Sinha Vikas See Remarks |
1,432 | $5.2145 | $7,467 | 14,359,194 (Indirect Direct) |
View |
2022-07-20 Sale |
2022-07-21 7:11 pm |
Allovir Inc. | ALVR | Atillasoy Ercem See Remarks |
563 | $5.2145 | $2,936 | 135,000 (Direct) |
View |
2022-07-20 Sale |
2022-07-21 7:11 pm |
Allovir Inc. | ALVR | VAN BEEK JEROEN B Chief Commercial Officer |
1,058 | $5.2145 | $5,517 | 401,953 (Direct) |
View |
2022-06-03 Sale |
2022-07-06 07:30 am |
Allovir Inc. | ALVR | VAN BEEK JEROEN B Chief Commercial Officer |
515 | $3.6321 | $1,871 | 429,011 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-08-16 Option Award |
2022-08-17 6:04 pm |
N/A N/A |
Allovir Inc. | ALVR | Leen Ann M. Chief Scientific Officer |
15,000 | $0 | 2,331,154 (Direct) |
View |
2022-08-16 Option Award |
2022-08-17 6:04 pm |
N/A N/A |
Allovir Inc. | ALVR | Sinha Vikas See Remarks |
100,000 | $0 | 17,712,990 (Direct) |
View |
2022-08-16 Option Award |
2022-08-17 6:02 pm |
N/A N/A |
Allovir Inc. | ALVR | Miller Edward General Counsel |
15,000 | $0 | 442,741 (Direct) |
View |
2022-08-16 Option Award |
2022-08-17 5:59 pm |
N/A N/A |
Allovir Inc. | ALVR | Brainard Diana Chief Executive Officer |
100,000 | $0 | 642,112 (Direct) |
View |
2022-08-16 Option Award |
2022-08-17 5:58 pm |
N/A N/A |
Allovir Inc. | ALVR | VAN BEEK JEROEN B Chief Commercial Officer |
15,000 | $0 | 401,363 (Direct) |
View |
2022-08-16 Option Award |
2022-08-17 5:57 pm |
N/A N/A |
Allovir Inc. | ALVR | Hagen Brett R Chief Accounting Officer |
20,000 | $0 | 113,578 (Direct) |
View |
Ownership |
2022-08-05 5:45 pm |
N/A N/A |
Allovir Inc. | ALVR | GILEAD SCIENCES INC. 10% Owner |
0 | $0 | 13,704,416 (Direct) |
View |
Ownership |
2022-08-05 4:15 pm |
N/A N/A |
Allovir Inc. | ALVR | F2 MG Ltd Globeways Holdings Ltd F2 - TPO Investments LLC F2 MC LLC F2 Capital I 2020 F2 Bioscience AV 2022 LLC Globeways Holdings II Ltd Director 10% Owner |
0 | $0 | 9,828,091 (Direct) |
View |
2022-07-28 Option Award |
2022-08-01 4:38 pm |
N/A N/A |
Allovir Inc. | ALVR | Sinha Vikas See Remarks 10% Owner |
3,253,796 | $4.61 | 17,612,990 (Indirect) |
View |
2022-07-28 Option Award |
2022-08-01 4:38 pm |
N/A N/A |
Allovir Inc. | ALVR | Hallal David Director 10% Owner |
3,253,796 | $4.61 | 20,607,546 (Indirect) |
View |
2022-07-28 Option Award |
2022-08-01 4:35 pm |
N/A N/A |
Allovir Inc. | ALVR | Jovan-Embiricos Morana Director 10% Owner |
8,152,247 | $4.61 | 16,704,963 (Indirect) |
View |
2022-07-28 Option Award |
2022-08-01 4:35 pm |
N/A N/A |
Allovir Inc. | ALVR | ElevateBio LLC Director 10% Owner |
3,253,796 | $4.61 | 16,674,766 (Direct) |
View |
2022-07-28 Option Award |
2022-08-01 4:34 pm |
N/A N/A |
Allovir Inc. | ALVR | GADICKE ANSBERT Director 10% Owner |
3,253,796 | $4.61 | 16,704,963 (Indirect) |
View |
2022-07-01 Option Award |
2022-07-06 07:30 am |
N/A 2032-07-01 |
Allovir Inc. | ALVR | Hagen Brett R Chief Accounting Officer |
30,000 | $0 | 113,078 (Direct) |
View |
2022-07-01 Option Award |
2022-07-06 07:30 am |
N/A 2032-07-01 |
Allovir Inc. | ALVR | Miller Edward General Counsel |
40,000 | $0 | 453,741 (Direct) |
View |
2022-07-01 Option Award |
2022-07-06 07:30 am |
N/A 2032-07-01 |
Allovir Inc. | ALVR | Sinha Vikas See Remarks |
84,000 | $0 | 14,415,226 (Direct) |
View |
2022-07-01 Option Award |
2022-07-06 07:30 am |
N/A 2032-07-01 |
Allovir Inc. | ALVR | VAN BEEK JEROEN B Chief Commercial Officer |
40,000 | $0 | 429,011 (Direct) |
View |
2022-07-01 Option Award |
2022-07-06 07:30 am |
N/A 2032-07-01 |
Allovir Inc. | ALVR | Atillasoy Ercem See Remarks |
40,000 | $0 | 161,563 (Direct) |
View |